Functional Technologies Corp.
TSX VENTURE : FEB

Functional Technologies Corp.

September 22, 2009 09:00 ET

Functional Technologies Grants Options

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 22, 2009) - Functional Technologies Corp. (TSX VENTURE:FEB) today reports that on September 16, 2009, options for the purchase of an aggregate of 305,000 common shares were granted to its non-management directors. These options are exercisable at a price of $0.60 per share for a period of five years and were issued under the company's revised option plan as approved by the shareholders at the Annual General Meeting held September 14, 2009.

About Functional Technologies Corp.

We develop and commercialize proprietary technologies that enhance the natural properties of yeast and micro-algae - nature's microscopic workhorses. Our scientists apply novel techniques in this under-exploited multi-billion dollar market to solve significant problems and generate new opportunities for the food, beverage and healthcare industries. We market our Phyterra™ proprietary yeast strains that reduce the formation of foul-smelling hydrogen sulfide and the carcinogen urethane in wines and other fermented products. With a head office in Vancouver, BC, Functional Technologies (TSX VENTURE:FEB) has research and production facilities in Prince Edward Island and a U.S. sales office in Napa Valley, CA. For more go to www.functionaltechcorp.com.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Contact Information